Published in Catheter Cardiovasc Interv on October 07, 2014
Predictors of Catastrophic Adverse Outcomes in Children With Pulmonary Hypertension Undergoing Cardiac Catheterization: A Multi-Institutional Analysis From the Pediatric Health Information Systems Database. J Am Coll Cardiol (2015) 3.09
Effect of center catheterization volume on risk of catastrophic adverse event after cardiac catheterization in children. Am Heart J (2015) 0.98
Relationship between hospital procedure volume and complications following congenital cardiac catheterization: A report from the IMproving Pediatric and Adult Congenital Treatment (IMPACT) registry. Am Heart J (2016) 0.75
A systematic approach to mapping recessive disease genes in individuals from outbred populations. PLoS Genet (2009) 3.06
Transcatheter device closure of atrial septal defects: a safety review. JACC Cardiovasc Interv (2013) 2.62
18 years of the Fontan operation at a single institution: results from 771 consecutive patients. J Am Coll Cardiol (2012) 2.24
COQ6 mutations in human patients produce nephrotic syndrome with sensorineural deafness. J Clin Invest (2011) 2.21
Hypoplastic left heart syndrome with atrial level restriction in the era of prenatal diagnosis. Ann Thorac Surg (2007) 2.10
A Proactive Approach to Neonates Born at 23 Weeks of Gestation. Obstet Gynecol (2015) 2.02
Preoperative brain injury in transposition of the great arteries is associated with oxygenation and time to surgery, not balloon atrial septostomy. Circulation (2009) 1.99
Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations. Clin J Am Soc Nephrol (2010) 1.93
Myocardial oxygenation and functional recovery in infarct rat hearts transplanted with mesenchymal stem cells. Am J Physiol Heart Circ Physiol (2009) 1.74
Aortic valvuloplasty in the fetus: technical characteristics of successful balloon dilation. J Pediatr (2005) 1.73
Systemic-to-pulmonary collateral flow, as measured by cardiac magnetic resonance imaging, is associated with acute post-Fontan clinical outcomes. Circ Cardiovasc Imaging (2012) 1.69
Characterization of radiation exposure and effect of a radiation monitoring policy in a large volume pediatric cardiac catheterization lab. Catheter Cardiovasc Interv (2011) 1.63
The precarious state of the liver after a Fontan operation: summary of a multidisciplinary symposium. Pediatr Cardiol (2012) 1.62
An in vitro comparison of the ability of three commonly used pediatric cardiopulmonary bypass circuits to filter gaseous microemboli. Perfusion (2010) 1.61
Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience. J Am Heart Assoc (2013) 1.59
Low weight as an independent risk factor for adverse events during cardiac catheterization of infants. Catheter Cardiovasc Interv (2013) 1.59
Use of a dose-dependent follow-up protocol and mechanisms to reduce patients and staff radiation exposure in congenital and structural interventions. Catheter Cardiovasc Interv (2011) 1.52
ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J Clin Invest (2013) 1.52
The frequency of cardiac arrests in patients with congenital heart disease undergoing cardiac catheterization. Anesth Analg (2014) 1.51
Sternal wall pressure comparable to leaning during CPR impacts intrathoracic pressure and haemodynamics in anaesthetized children during cardiac catheterization. Resuscitation (2013) 1.49
Open-cell design stents in congenital heart disease: a comparison of IntraStent vs. Palmaz stents. Catheter Cardiovasc Interv (2002) 1.47
ACC/AHA/AAP recommendations for training in pediatric cardiology. Pediatrics (2005) 1.46
Adverse events rates and risk factors in adults undergoing cardiac catheterization at pediatric hospitals--results from the C3PO. Catheter Cardiovasc Interv (2013) 1.46
Comparison of surgical, stent, and balloon angioplasty treatment of native coarctation of the aorta: an observational study by the CCISC (Congenital Cardiovascular Interventional Study Consortium). J Am Coll Cardiol (2011) 1.39
Obstruction of the superior vena cava after neonatal extracorporeal membrane oxygenation: association with chylothorax and outcome of transcatheter treatment. Pediatr Crit Care Med (2013) 1.37
Cardiovascular abnormalities, interventions, and long-term outcomes in infantile Williams syndrome. J Pediatr (2009) 1.36
Noninvasive quantification of systemic-to-pulmonary collateral flow: a major source of inefficiency in patients with superior cavopulmonary connections. Circ Cardiovasc Imaging (2009) 1.32
Long-term outcomes of patients with cardiovascular abnormalities and williams syndrome. Am J Cardiol (2010) 1.30
Students' and residents' perceptions regarding technology in medical training. Acad Psychiatry (2006) 1.29
Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression. J Pharmacol Exp Ther (2009) 1.21
Portal and sinusoidal fibrosis are common on liver biopsy after Fontan surgery. Pediatr Cardiol (2012) 1.18
Controversies, genetics, diagnostic assessment, and outcomes relating to the heterotaxy syndrome. Cardiol Young (2007) 1.18
X-ray magnetic resonance fusion to internal markers and utility in congenital heart disease catheterization. Circ Cardiovasc Imaging (2011) 1.17
HO-3867, a synthetic compound, inhibits the migration and invasion of ovarian carcinoma cells through downregulation of fatty acid synthase and focal adhesion kinase. Mol Cancer Res (2010) 1.16
Use of angiographic CT imaging in the cardiac catheterization laboratory for congenital heart disease. JACC Cardiovasc Imaging (2010) 1.14
Kinetic analysis of human T-cell leukemia virus type 1 gene expression in cell culture and infected animals. J Virol (2009) 1.14
Transcatheter treatment for systemic-to-pulmonary artery shunt obstruction in infants and children. Catheter Cardiovasc Interv (2008) 1.11
Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation (2004) 1.11
Intervention for recoarctation in the single ventricle reconstruction trial: incidence, risk, and outcomes. Circulation (2013) 1.10
Extensive genetic diversity and substructuring among zebrafish strains revealed through copy number variant analysis. Proc Natl Acad Sci U S A (2011) 1.10
Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. Int J Cancer (2009) 1.07
Synthesis of phosphorus-doped graphene and its multifunctional applications for oxygen reduction reaction and lithium ion batteries. Adv Mater (2013) 1.06
Exercise restriction to prevent sudden death in congenital aortic stenosis: whom are we treating? J Am Coll Cardiol (2010) 1.06
Endomyocardial biopsy and selective coronary angiography are low-risk procedures in pediatric heart transplant recipients: results of a multicenter experience. J Heart Lung Transplant (2011) 1.06
Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling. FEBS J (2012) 1.05
X-ray magnetic resonance fusion modality may reduce radiation exposure and contrast dose in diagnostic cardiac catheterization of congenital heart disease. Catheter Cardiovasc Interv (2014) 1.05
Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart. J Mol Cell Cardiol (2009) 1.05
Placental transfusion strategies in very preterm neonates: a systematic review and meta-analysis. Obstet Gynecol (2014) 1.04
Ventricular function deteriorates with recurrent coarctation in hypoplastic left heart syndrome. Ann Thorac Surg (2008) 1.02
Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts. Mol Cancer Ther (2010) 1.02
Noninvasive estimation of ventricular filling pressures in patients with single right ventricles. J Am Soc Echocardiogr (2013) 1.01
The IMPACT registry: IMproving Pediatric and Adult Congenital Treatments. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu (2010) 1.01
Patient radiation exposure in a modern, large-volume, pediatric cardiac catheterization laboratory. Pediatr Cardiol (2014) 1.00
HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer. Cancer Res (2014) 1.00
Platelet-endothelial cell adhesion molecule-1-directed immunotargeting to cardiopulmonary vasculature. J Pharmacol Exp Ther (2002) 1.00
The Medtronic Melody® transcatheter pulmonary valve implanted at 24-mm diameter--it works. Catheter Cardiovasc Interv (2013) 0.99
Impact of re-coarctation following the Norwood operation on survival in the balloon angioplasty era. J Am Coll Cardiol (2005) 0.99
MRI of lymphatic abnormalities after functional single-ventricle palliation surgery. AJR Am J Roentgenol (2014) 0.99
Safety and efficacy of balloon pulmonary valvuloplasty: a multicenter experience. Catheter Cardiovasc Interv (2012) 0.98
Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: differential cytotoxicity in healthy and cancer cells. Free Radic Biol Med (2010) 0.97
Incidence and management of life-threatening adverse events during cardiac catheterization for congenital heart disease. Pediatr Cardiol (2013) 0.97
Distinct transformation tropism exhibited by human T lymphotropic virus type 1 (HTLV-1) and HTLV-2 is the result of postinfection T cell clonal expansion. J Virol (2012) 0.96
Balloon angioplasty and stenting of branch pulmonary arteries: adverse events and procedural characteristics: results of a multi-institutional registry. Circ Cardiovasc Interv (2011) 0.95
HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition. Cancer Biol Ther (2011) 0.95
Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events. Catheter Cardiovasc Interv (2014) 0.94
Inhibition of vascular smooth-muscle cell proliferation and arterial restenosis by HO-3867, a novel synthetic curcuminoid, through up-regulation of PTEN expression. J Pharmacol Exp Ther (2009) 0.94
Acute effects of embolizing systemic-to-pulmonary arterial collaterals on blood flow in patients with superior cavopulmonary connections: a pilot study. Circ Cardiovasc Interv (2013) 0.93
Outcomes after primary transcatheter therapy in infants and young children with severe bilateral peripheral pulmonary artery stenosis. Circ Cardiovasc Interv (2013) 0.93
Nineteen novel NPHS1 mutations in a worldwide cohort of patients with congenital nephrotic syndrome (CNS). Nephrol Dial Transplant (2010) 0.92
Bare metal stenting for obstructed small diameter homograft conduits in the right ventricular outflow tract. Catheter Cardiovasc Interv (2012) 0.92
Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling. Carcinogenesis (2013) 0.92
Reproducibility of echocardiographic diagnosis of left ventricular noncompaction. J Am Soc Echocardiogr (2011) 0.92
Cardiac magnetic resonance and the need for routine cardiac catheterization in single ventricle patients prior to Fontan: a comparison of 3 groups: pre-Fontan CMR versus cath evaluation. J Am Coll Cardiol (2012) 0.91
Synthesis of N-substituted 3,5-bis(arylidene)-4-piperidones with high antitumor and antioxidant activity. J Med Chem (2011) 0.91
Oxygenation inhibits ovarian tumor growth by downregulating STAT3 and cyclin-D1 expressions. Cancer Biol Ther (2010) 0.90
Bloodstream infections occurring in patients with percutaneously implanted bioprosthetic pulmonary valve: a single-center experience. Circ Cardiovasc Interv (2013) 0.90
Guidelines for the outpatient management of complex congenital heart disease. Congenit Heart Dis (2006) 0.89
An evaluation of a noninvasive cardiac output measurement using partial carbon dioxide rebreathing in children. Anesth Analg (2004) 0.89
Percutaneous transvenous Melody valve-in-ring procedure for mitral valve replacement. J Am Coll Cardiol (2011) 0.89
Building nanocomposite magnets by coating a hard magnetic core with a soft magnetic shell. Angew Chem Int Ed Engl (2014) 0.89
The Amplatzer vascular plug and Amplatzer vascular plug II for vascular occlusion procedures in 50 patients with congenital cardiovascular disease. Catheter Cardiovasc Interv (2010) 0.88
Pediatric catheterization laboratory anticoagulation with bivalirudin. Catheter Cardiovasc Interv (2011) 0.88
Melody valve implantation into the branch pulmonary arteries for treatment of pulmonary insufficiency in an ovine model of right ventricular outflow tract dysfunction following tetralogy of Fallot repair. Circ Cardiovasc Interv (2011) 0.88
Melody valve implant within failed bioprosthetic valves in the pulmonary position: a multicenter experience. Circ Cardiovasc Interv (2012) 0.88
Late catheter interventions in hypoplastic left heart syndrome. Cardiol Young (2011) 0.88